Literature DB >> 15564892

The serotonin-2A receptor polymorphism and smoking behavior in Japan.

Hayato Terayama1, Masahiro Itoh, Isao Fukunishi, Kazuhiko Iwahashi.   

Abstract

Epidemiological and genetic studies on smoking behavior have been performed, and in this study the human serotonin 2A receptor (HTR2A) polymorphism was examined in 82 smoking behaviorists and 125 healthy controls. HTR2A consists of at least 14 subtypes, depression and anxiety occur due to agonists, and hallucination, fever heat, psychomotor excitement and other symptoms also occur. The polymorphism in HTR2A (102T/C, -1438A/G) was identified by means of the polymerase chain reaction followed by restriction fragment length polymorphism, and the Fagerstrom Test for Nicotine Dependence was used to determine the extent of smoking behavior. The results suggest that the HTR2A (102T/C, -1438G/A) polymorphism might not be associated with susceptibility to a risk factor for developing smoking behavior. Further studies are required to determine whether or not the novel serotonin receptor (5-HTR) polymorphism reflects the pathogenesis of smoking behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564892     DOI: 10.1097/00041444-200412000-00005

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  3 in total

1.  'Smoking genes': a genetic association study.

Authors:  Zoraida Verde; Catalina Santiago; José Miguel Rodríguez González-Moro; Pilar de Lucas Ramos; Soledad López Martín; Fernando Bandrés; Alejandro Lucia; Félix Gómez-Gallego
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

2.  Lack of Association between the Serotonin Transporter (5-HTT) and Serotonin Receptor (5-HT2A) Gene Polymorphisms with Smoking Behavior among Malaysian Malays.

Authors:  Nur Iwani A Rozak; Imran Ahmad; Siew Hua Gan; Ruzilawati Abu Bakar
Journal:  Sci Pharm       Date:  2014-07-18

3.  Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity.

Authors:  Gloria Pérez-Rubio; Alejandra Ramírez-Venegas; Valeri Noé Díaz; Leonor García Gómez; Karina Elvira Fabián; Salvador García Carmona; Luis A López-Flores; Enrique Ambrocio-Ortiz; Rocío Contreras Romero; Noé Alcantar-Ayala; Raúl H Sansores; Ramcés Falfán-Valencia
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.